ES2195992T3 - Acido nucleico que codifica la enzima de conversion de la angiotensina (eca) testicular humana y sus aplicaciones, en particular para la deteccion in vitro de dicha enzima en el organismo. - Google Patents

Acido nucleico que codifica la enzima de conversion de la angiotensina (eca) testicular humana y sus aplicaciones, en particular para la deteccion in vitro de dicha enzima en el organismo.

Info

Publication number
ES2195992T3
ES2195992T3 ES90910749T ES90910749T ES2195992T3 ES 2195992 T3 ES2195992 T3 ES 2195992T3 ES 90910749 T ES90910749 T ES 90910749T ES 90910749 T ES90910749 T ES 90910749T ES 2195992 T3 ES2195992 T3 ES 2195992T3
Authority
ES
Spain
Prior art keywords
eca
nucleic acid
vitro detection
enzym
organism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90910749T
Other languages
English (en)
Inventor
Florent Soubrier
Francois Alhenc-Gelas
Christine Hubert
Pierre Corvol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of ES2195992T3 publication Critical patent/ES2195992T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA INVENCION TIENE POR OBJETO EL CLONADO Y SECUENCIADO DEL ACIDO NUCLEICO CODIFICANTE PARA EL ECA TESTICULAR HUMANO, ASI COMO LA DETERMINACION DE LA SECUENCIA PEPEPTIDICA DE ESA ECA. TIENE MAS PARTICULARMENTE COMO OBJETO LA UTILIZACION DE SONDAS NUCLEOTIDICAS SUSCEPTIBLES DE HIBRIDARSE CON TODA O PARTE DEL ACIDO NUCLEICO MENCIONADO ANTES, O BIEN CON LOS ANTICUERPOS POLICLONALES O MONOCLONALES RECONOCIENDO TODO O PARTE DE LA SECUENCIA PEPTIDICA MENCIONADA MAS ARRIBA, Y LA UTILIZACION DE ESAS SONDAS O DE ESOS ANTICUERPOS PARA LA PUESTA EN MARCHA RESPECTIVAMENTE DE UN METODO DE DETECCION IN VITRO DEL ARN MENSAJERO CODIFICANTE PARA LA ECA TESTICULAR O DIRECTAMENTE DE LA ECA TESTICULAR.
ES90910749T 1989-07-05 1990-07-05 Acido nucleico que codifica la enzima de conversion de la angiotensina (eca) testicular humana y sus aplicaciones, en particular para la deteccion in vitro de dicha enzima en el organismo. Expired - Lifetime ES2195992T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8909062A FR2649412B1 (fr) 1989-07-05 1989-07-05 Acide nucleique codant pour l'enzyme de conversion de l'angiotensine (eca) testiculaire humaine, et ses applications, notamment pour le depistage in vitro de cette enzyme dans l'organisme

Publications (1)

Publication Number Publication Date
ES2195992T3 true ES2195992T3 (es) 2003-12-16

Family

ID=9383508

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90910749T Expired - Lifetime ES2195992T3 (es) 1989-07-05 1990-07-05 Acido nucleico que codifica la enzima de conversion de la angiotensina (eca) testicular humana y sus aplicaciones, en particular para la deteccion in vitro de dicha enzima en el organismo.

Country Status (10)

Country Link
US (1) US5801040A (es)
EP (1) EP0432254B1 (es)
JP (1) JPH04500612A (es)
AT (1) ATE238423T1 (es)
CA (1) CA2035888C (es)
DE (1) DE69034060T2 (es)
DK (1) DK0432254T3 (es)
ES (1) ES2195992T3 (es)
FR (1) FR2649412B1 (es)
WO (1) WO1991000354A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678285A1 (fr) * 1991-06-27 1992-12-31 Inst Nat Sante Rech Med Moyens et procedes pour l'etude du polymorphisme genetique de l'enzyme de conversion de l'angiotensine 1.
WO1999015643A2 (en) * 1997-09-25 1999-04-01 University Of Florida ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO ANGIOTENSI N CONVERTING ENZYME mRNA AND METHODS OF USE
US6194556B1 (en) 1997-12-11 2001-02-27 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therfor
US6610497B1 (en) * 1997-12-11 2003-08-26 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor
US6989363B1 (en) 1997-12-11 2006-01-24 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor
US6525185B1 (en) * 1998-05-07 2003-02-25 Affymetrix, Inc. Polymorphisms associated with hypertension
US6280994B1 (en) * 1998-11-25 2001-08-28 Zymogenetics, Inc. Zace 1: a human metalloenzyme
AU4691900A (en) * 1999-05-13 2000-12-05 Zymogenetics Inc. Zace2: a human metalloenzyme
GB0221169D0 (en) * 2002-09-12 2002-10-23 Univ Bath Crystal
EP1570854A4 (en) 2002-10-29 2008-07-30 Gen Kondoh DRUGS WITH ANGIOTENSINE CONVERTASE
GB0600406D0 (en) 2006-01-10 2006-02-15 Univ Bath Crystal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276378A (en) * 1977-11-25 1981-06-30 Ryan James W High sensitivity assays for angiotensin converting enzyme
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme

Also Published As

Publication number Publication date
ATE238423T1 (de) 2003-05-15
CA2035888C (fr) 2006-11-28
EP0432254B1 (fr) 2003-04-23
WO1991000354A1 (fr) 1991-01-10
US5801040A (en) 1998-09-01
CA2035888A1 (fr) 1991-01-06
FR2649412A1 (fr) 1991-01-11
DK0432254T3 (da) 2003-08-11
DE69034060T2 (de) 2004-02-26
EP0432254A1 (fr) 1991-06-19
JPH04500612A (ja) 1992-02-06
DE69034060D1 (de) 2003-05-28
FR2649412B1 (fr) 1995-10-20

Similar Documents

Publication Publication Date Title
ES2195992T3 (es) Acido nucleico que codifica la enzima de conversion de la angiotensina (eca) testicular humana y sus aplicaciones, en particular para la deteccion in vitro de dicha enzima en el organismo.
ATE106940T1 (de) Für das polypeptid des t-zellantigenreceptors kodierende nukleinsäure.
Lirazan et al. The spasmodic peptide defines a new conotoxin superfamily
MD430C2 (ro) Procedeu de obţinere a interferonelor leucocitare umane
ES2092976T1 (es) Metodo para la modificacion de los habitos alimenticios.
EA200400312A1 (ru) АНТАГОНИСТИЧЕСКИЕ АНТИТЕЛА ПРОТИВ hTNFSF13b ЧЕЛОВЕКА
PT770088E (pt) Nova citoquina designada lerk-5
ES2153333T1 (es) Medidor biosensor con metodo de estimacion de la temperatura ambiente y sistema.
DE59903410D1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
ATE319818T1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
ES2153444T3 (es) Anticuerpos contra interleucina-4 mamifera, y peptidos utiles como antigenos en su produccion.
WO1999057144A3 (en) Human transcriptional regulator molecules
DK0500602T3 (da) Middel til neutralisering af til tumorceller knyttet prokoagulantaktivitet
DK0724637T3 (da) Kortikotropinfrigørende faktor2-receptorer
WO2000017355A3 (en) Human cytoskeleton associated proteins
DK0643719T3 (da) Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor
DE69632963D1 (de) Mch3, eine apoptosis-protease, kodierende nukleinsäuren und methoden zur verwendung
DE69433902D1 (de) Neuartige tyrosinkinase
ES8605296A1 (es) Procedimiento de producir factor viii-r humano
DE60330564D1 (de) Verfahren und konstrukte zur expression von clostripain mit hoher ausbeute
Williams The practical uses of AC-DC transfer instruments
ES2111537T3 (es) Inhibidor de la ribonucleasa de placenta humana recombinante y metodo de produccion.
CY1110794T1 (el) Μεθοδοι μετατροπης ισομορφων ιντερφερονης και προϊοντων της
ES2154678T3 (es) Eliminacion de compuestos de azufre de corrientes de hidrocarburos que contienen una proporcion mayoritaria de compuestos reactivos insaturados.
ES2191078T3 (es) Procedimiento de obtencion de d,1-alfa-tocoferol en presencia de un catalizador de acido perfluoroalquilensulfonico.